Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06165848
Other study ID # 11260011
Secondary ID Ayça Tuba Dumanl
Status Completed
Phase
First received
Last updated
Start date July 9, 2020
Est. completion date June 7, 2021

Study information

Verified date December 2023
Source T.C. Saglik Bakanligi Ankara Bilkent Sehir Hastanesi
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Adequate and effective pain management and prevention of depression are essential in burn patients. This study aims to investigate the effects of ketamine sedation in burn patients in terms of mood disorders, depression, anxiety, and suicidal tendency during intensive care follow-up in the postoperative period.


Description:

Aim: Adequate and effective pain management and prevention of depression are essential in burn patients. This study aims to investigate the effects of ketamine sedation in burn patients in terms of mood disorders, depression, anxiety, and suicidal tendency during intensive care follow-up in the postoperative period. Methods: The study was conducted with 67 patients between 18 and 65 years of age, who were ASA I-II class, had basic communication skills, no previous diagnosis of psychiatric illness, and no history of neuropsychiatric or cognitive disease or related treatment. After preoxygenation, anesthesia induction was performed with 2 mg/kg IV propofol and 1 mcg/kg IV fentanyl in the general anesthesia group. Anesthesia was continued with a mixture of 0.3-0.5 mcg/kg/min remifentanil, 2% sevoflurane, 50% air, 50% oxygen. In the sedation group, 1 mcg/kg IV fentanyl and 1 mg/kg IV ketamine were administered at induction; anesthesia was maintained by adding 30-50 mg IV propofol if necessary. The Montgomery-Asberg Depression Rating Scale (MADRS), the Hamilton Anxiety Rating Scale (HAM-A), and the Beck Scale for Suicide Ideation (BSSI) were administered preoperatively and on postoperative day one by the psychiatrist.


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date June 7, 2021
Est. primary completion date August 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Who were ASA I-II class, - Had basic communication skills, - No previous diagnosis of psychiatric illness, - No history of neuropsychiatric or cognitive disease or related treatment. Exclusion Criteria: - With a previous diagnosis of psychiatric illness, - Neuropsychiatric or cognitive illness, - Or a history of related treatment.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Ankara Bilkent Sehir Hastanesi Ankara

Sponsors (1)

Lead Sponsor Collaborator
T.C. Saglik Bakanligi Ankara Bilkent Sehir Hastanesi

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J — View Citation

Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, Owoeye O, Batten LA, Blier P. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. Am J Psychiatry. 2019 May 1;176(5):40 — View Citation

Phillips JL, Norris S, Talbot J, Hatchard T, Ortiz A, Birmingham M, Owoeye O, Batten LA, Blier P. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology. 2020 Mar;45(4):606-612. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Montgomery-Asberg Depression Rating Scale (MADRS), In order to determine whether there is negative mood and depression; Montgomery-Asberg Depression Rating Scale (MADRS) was administered by the psychiatrist . 72 hours
Primary Hamilton Anxiety Rating Scale (HAM-A) For anxiety; Hamilton Anxiety Rating Scale (HAM-A) was administered by the psychiatrist . 72 hours
Primary Beck Suicidal Ideation Scale (BSSI) To determine whether there is suicidal ideation; Beck Suicidal Ideation Scale (BSSI) was administered by the psychiatrist . 72 hours
See also
  Status Clinical Trial Phase
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Recruiting NCT05539521 - Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation Phase 2
Completed NCT01170156 - Fluid Leakage Past Tracheal Tube Cuff : Effect of Suctioning Manoeuvre N/A
Terminated NCT02903407 - Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU Phase 4
Completed NCT04695509 - Sedation and Neuromediators Concentration N/A
Not yet recruiting NCT03687385 - The Effect of High-flow Nasal Oxygenation to the Saturation During Analgo-sedation in Different ASA Risk Class Patients N/A
Not yet recruiting NCT03687424 - Can High-flow Nasal Oxygenation Improve Oxygen Saturation During Analgo-sedation in Obese Adults? N/A
Completed NCT02302391 - Pharmacokinetic Analysis of Midazolam and Fentanyl in Pediatric Patients With Long-term Analgosedation
Recruiting NCT03893877 - Comparison of Oxygenation Methods in Sedation N/A
Completed NCT00639548 - ERPS, BIS and Entropy for Neuromonitoring in ICU Patients N/A
Terminated NCT04168294 - The Influence of Sedation for Endoscopy on Cognitive Function
Withdrawn NCT04026451 - Spectral Edge Frequency From Spectral EEG Analysis to Guide Deep Sedation in the Critical Care Setting (Pilot) N/A
Completed NCT05163704 - Dexmedetomidine Sedation in Children Before MRI Examinations N/A
Completed NCT05587803 - Comparison of 2 Depth of Sedation Indices in the Intensive Care Unit N/A
Completed NCT04141267 - Inhaled Sedation Using the Anesthetic-conserving Device ( ANACONDA) in Prehospital Emergency Medecine.
Active, not recruiting NCT02909010 - Bispectral Index Monitoring To Guide Sedation In The Critical Care Setting N/A
Completed NCT03652324 - What Should be the Anesthesia Method in Endobronchial Coil Treatment N/A
Completed NCT00717574 - Addition of Nitrous Oxide and Its Effects on Depth of Anesthesia N/A
Completed NCT00641563 - Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG) N/A
Not yet recruiting NCT06436638 - Comparison of Nasal Continuous Positive Airway Pressure (CPAP) Mask and Nasal Airway in Molar Tooth Extraction Under Deep Sedation